Defining risk in MDS over time
Blood
.
2016 Aug 18;128(7):885-6.
doi: 10.1182/blood-2016-07-724930.
Authors
Akihide Yoshimi
1
,
Omar Abdel-Wahab
1
Affiliation
1
MEMORIAL SLOAN KETTERING CANCER CENTER.
PMID:
27539994
DOI:
10.1182/blood-2016-07-724930
No abstract available
Publication types
Comment
MeSH terms
Humans
Myelodysplastic Syndromes*
Risk